July 2023 Price Concessions Final Update
THIS CONTENT HAS NOW EXPIRED
Drug | Pack size | Price concession |
Aciclovir 200mg tablets | 25 | £1.76 |
Atorvastatin 20mg tablets | 28 | £3.38 |
Atorvastatin 80mg tablets | 28 | £3.45 |
Benzoyl peroxide 5% / Clindamycin 1% gel | 30 | £11.09 |
Benzoyl peroxide 5% / Clindamycin 1% gel | 60 | £21.65 |
Betahistine 16mg tablets | 84 | £8.92 |
Betahistine 8mg tablets | 84 | £3.73 |
Brinzolamide 10mg/ml / Timolol 5mg/ml eye drops | 5 | £8.19 |
Buprenorphine 8mg sublingual tablets sugar free | 7 | £4.22 |
Calcipotriol 0.005% / Betamethasone dipropionate 0.05% ointment | 30 | £10.67 |
Celecoxib 100mg capsules | 60 | 5.12 |
Cinacalcet 30mg tablets | 28 | £7.77 |
Cinnarizine 15mg tablets | 84 | £5.47 |
Clarithromycin 250mg/5ml oral suspension | 70 | £4.88 |
Co-amoxiclav 250mg/125mg tablets | 21 | £2.69 |
Co-amoxiclav 250mg/62mg/5ml oral suspension sugar free | 100 | £2.09 |
Co-careldopa 12.5mg/50mg tablets | 90 | £4.56 |
Codeine 30mg tablets | 28 | £1.08 |
Codeine 30mg tablets | 100 | £3.86 |
Desmopressin 200microgram tablets | 30 | 21.69 |
Dorzolamide 20mg/ml eye drops | 5 | £3.34 |
Doxycycline 100mg capsules | 8 | 1.02 |
Enalapril 2.5mg tablets | 28 | £8.75 |
Estradiol 10microgram pessaries | 24 | 10.69 |
Fenofibrate micronised 200mg capsules | 28 | £3.43 |
Flucloxacillin 250mg/5ml oral solution | 100 | £3.40 |
Flucloxacillin 250mg/5ml oral solution sugar free | 100 | £3.51 |
Fludrocortisone 100microgram tablets | 30 | £6.43 |
Hydralazine 25mg tablets | 56 | £4.40 |
Hydrocortisone 1% cream | 15 | £0.99 |
Itraconazole 100mg capsules | 15 | £4.27 |
Lansoprazole 15mg orodispersible tablets | 28 | £2.97 |
Letrozole 2.5mg tablets | 14 | £5.89 |
Mebeverine 50mg/5ml oral suspension sugar free | 300 | £214.96 |
Mometasone 0.1% ointment | 30 | £3.84 |
Morphine sulfate 10mg/1ml solution for injection ampoules | 10 | £7.49 |
Naftidrofuryl 100mg capsules | 84 | £10.20 |
Pantoprazole 40mg gastro-resistant tablets | 28 | £3.53 |
Paracetamol 500mg effervescent tablets | 100 | £8.80 |
Pregabalin 150mg capsules | 56 | £2.67 |
Quinine sulfate 200mg tablets | 28 | £7.87 |
Rizatriptan 10mg orodispersible tablets sugar free | 3 | £6.02 |
Sodium chloride 0.9% nebuliser liquid 2.5ml unit dose ampoules | 20 | £11.75 |
Tacrolimus 0.1% ointment | 30 | £19.23 |
Tacrolimus 0.1% ointment | 60 | £40.94 |
Telmisartan 20mg tablets | 28 | £3.82 |
Terbinafine 1% cream | 30 | £7.27 |
Terbinafine 1% cream | 15 | £3.26 |
Topiramate 100mg tablets | 60 | £12.35 |
Topiramate 50mg tablets | 60 | £16.14 |
Trazodone 100mg capsules | 56 | £3.05 |
Trihexyphenidyl 2mg tablets | 84 | £3.74 |
Valsartan 40mg capsules | 28 | £6.75 |
Please note: DHSC has agreed to roll over the following price concessions to August 2023:
- Cinnarizine 15mg tablets (84) £5.47
- Co-amoxiclav 250mg/125mg tablets (21) £2.69
- Co-careldopa 12.5mg/50mg tablets (90) £4.56
For the full list of price concessions granted for July 2023, please visit our webpage: cpe.org.uk/priceconcessions
No additional endorsements are required for price concessions. A price concession only applies for the month it is granted; any prices agreed for concessions requested late in the month will roll over into the following month.
We encourage pharmacies to report any problems obtaining a Part VIII product at or below the stated Drug Tariff price, using the online feedback form on the Community Pharmacy England website. Please include full details of the supplier and price paid for any products sourced above the Drug Tariff price. We will investigate the extent of the problem and, if appropriate, discuss the issue with DHSC.
Please subscribe to our mailing list to receive email updates of any price concessions.
Further information on price concessions and FAQs about the process involved can be found on our website (cpe.org.uk/priceconcessions) To hear more on how the current price concessions system operates, pharmacy teams can now access a recording of our recent webinar here.
Improvements to the price concession system
Following significant concerns raised by pharmacies about the unsustainable level of prices imposed by DHSC in second half of 2022, it was agreed that an urgent review of the price concession setting system would take place.
Since this announcement, we have sent a strong and clear message back to Government that pharmacies cannot continue to subsidise the NHS medicines bill. Following the review of the concessionary price process, a package of measures has been developed to improve the system.
One of the solutions agreed between us and DHSC is that from 1st April 2023, all products granted a concessionary price will be classified as ‘Discount Not Deducted’ for the month(s) in which they are on concession.
Furthermore, from May 2023, DHSC has implemented a process to roll over prices to the following month for any concessions requested after the 23rd of the month provided these prices were agreed with us. We are also continuing to work with DHSC on how a ‘retrospective increased payment’ my apply, when appropriate. Further information regarding this concession ‘top-up’ mechanism will be issued once details are finalised.